Agios Pharmaceuticals Inc’s recently made public that its Principal Accounting Officer Washburn Theodore James Jr. unloaded Company’s shares for reported $43301.0 on Nov 08 ’24. In the deal valued at $56.09 per share,772 shares were sold. As a result of this transaction, Washburn Theodore James Jr. now holds 813 shares worth roughly $43723.14.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Ballal Rahul D. sold 10,000 shares, generating $581,911 in total proceeds. Upon selling the shares at $58.19, the Director now owns 7,992 shares.
Before that, Ballal Rahul D. sold 10,000 shares. Agios Pharmaceuticals Inc shares valued at $535,236 were divested by the Director at a price of $53.52 per share. As a result of the transaction, Ballal Rahul D. now holds 7,992 shares, worth roughly $0.43 million.
Scotiabank initiated its Agios Pharmaceuticals Inc [AGIO] rating to a Sector outperform in a research note published recently. Leerink Partners also remained covering AGIO and has decreased its forecast on September 27, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on February 08, 2024. It rated AGIO as “an Overweight”.
Price Performance Review of AGIO
On Friday, Agios Pharmaceuticals Inc [NASDAQ:AGIO] saw its stock fall -2.92% to $53.78. Over the last five days, the stock has lost -8.94%. Agios Pharmaceuticals Inc shares have risen nearly 141.49% since the year began. Nevertheless, the stocks have risen 139.34% over the past one year. While a 52-week high of $62.58 was reached on 11/11/24, a 52-week low of $20.96 was recorded on 01/19/24. SMA at 50 days reached $46.44, while 200 days put it at $39.50.
Levels Of Support And Resistance For AGIO Stock
The 24-hour chart illustrates a support level at 52.46, which if violated will result in even more drops to 51.13. On the upside, there is a resistance level at 55.39. A further resistance level may holdings at 56.99. The Relative Strength Index (RSI) on the 14-day chart is 59.21, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.00, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 45.53%. Stochastics %K at 65.58% indicates the stock is a holding.
How much short interest is there in Agios Pharmaceuticals Inc?
A steep rise in short interest was recorded in Agios Pharmaceuticals Inc stocks on 2024-10-31, growing by 1.06 million shares to a total of 4.34 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.28 million shares. There was a rise of 24.53%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 03, 2023 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $41 price target.
